Literature DB >> 11592823

Structure-function analyses of a common mutation in blacks with transferase-deficiency galactosemia.

K Lai1, L J Elsas.   

Abstract

We previously identified a missense mutation at amino acid 135 of human galactose 1-phosphate uridyltransferase (hGALT) in which a leucine (TTG) was substituted for a serine (TCG), S135L. This mutation was common in black patients with galactosemia and homozygotes (S135L/S135L) had no GALT activity or protein in their erythrocytes or lymphoblasts. However, there was residual GALT activity and protein in their leukocytes, and they had near normal total body [13C]galactose oxidation to 13CO2 in breath. To evaluate the biochemical mechanism(s) producing these effects, we overexpressed hGALT proteins with site-directed mutations in this nonconserved amino acid in a GALT-minus Escherichia coli. Enzyme activities detected in bacterial lysates overexpressing either S135 (wild type), A135, C135, H135, L135, S132-H135, T135, or Y135 were 100, 4.7, 3.0, 4.0, 2.7, 0.7, 35.4, and 1.4%, respectively. Only the threonine substitution (S135T) had significant enzyme activity in these lysates. There was also decreased abundance of all mutant proteins in the lysates exposed to bacterial proteolysis during preparation and analysis. This added the variable of bio-instability to analysis of enzyme activities in lysates. To further characterize the catalytic role of serine at amino acid 135 and to differentiate bio-instability from impaired catalysis by the leucine substitution, we purified wild-type and L135-hGALT proteins to homogeneity and analyzed identical amounts of enzyme protein. We found that the apparent Vmax of the purified L135-hGALT protein was significantly reduced from 80 +/- 5.9 to 5.8 +/- 1.8 micromol glucose 1-phosphate released/min/mg hGALT protein with no increase in KM for galactose 1-phosphate for the second displacement. The first displacement reaction, although three orders of magnitude slower, was similar between the wild type and L135-hGALT. We conclude that a hydroxyl group on amino acid 135 is required for the catalysis of uridyl transfer from UDP-glucose to UDP-galactose in the presence of galactose 1-phosphate, and plays a role in the bio-stability of hGALT. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592823     DOI: 10.1006/mgme.2001.3230

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  13 in total

1.  Biochemical changes and clinical outcomes in 34 patients with classic galactosemia.

Authors:  Tatiana Yuzyuk; Krista Viau; Ashley Andrews; Marzia Pasquali; Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2018-01-19       Impact factor: 4.982

2.  Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.

Authors:  Thomas J McCorvie; Tyler J Gleason; Judith L Fridovich-Keil; David J Timson
Journal:  Biochim Biophys Acta       Date:  2013-04-11

3.  Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.

Authors:  Emily L Ryan; Mary Ellen Lynch; Elles Taddeo; Tyler J Gleason; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2013-01-15       Impact factor: 4.982

4.  Simultaneous amplification, detection, and analysis of common mutations in the galactose-1-phosphate uridyl transferase gene.

Authors:  Mohamed Jama; Lesa Nelson; Genevieve Pont-Kingdon; Rong Mao; Elaine Lyon
Journal:  J Mol Diagn       Date:  2007-09-20       Impact factor: 5.568

Review 5.  Galactose toxicity in animals.

Authors:  Kent Lai; Louis J Elsas; Klaas J Wierenga
Journal:  IUBMB Life       Date:  2009-11       Impact factor: 3.885

6.  Negative screening tests in classical galactosaemia caused by S135L homozygosity.

Authors:  E Crushell; J Chukwu; P Mayne; J Blatny; E P Treacy
Journal:  J Inherit Metab Dis       Date:  2009-05-08       Impact factor: 4.982

7.  Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Marzia Pasquali; Chunli Yu; Bradford Coffee
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

8.  Functional and structural impact of the most prevalent missense mutations in classic galactosemia.

Authors:  Ana I Coelho; Matilde Trabuco; Ruben Ramos; Maria João Silva; Isabel Tavares de Almeida; Paula Leandro; Isabel Rivera; João B Vicente
Journal:  Mol Genet Genomic Med       Date:  2014-06-23       Impact factor: 2.183

Review 9.  Sweet and sour: an update on classic galactosemia.

Authors:  Ana I Coelho; M Estela Rubio-Gozalbo; João B Vicente; Isabel Rivera
Journal:  J Inherit Metab Dis       Date:  2017-03-09       Impact factor: 4.982

10.  Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase.

Authors:  Thomas J McCorvie; Jolanta Kopec; Angel L Pey; Fiona Fitzpatrick; Dipali Patel; Rod Chalk; Leela Shrestha; Wyatt W Yue
Journal:  Hum Mol Genet       Date:  2016-03-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.